Home page Home page

NeuroBloc
botulinum toxin type B

Package leaflet: Information for the user


NeuroBloc 5000 U/ml Solution for Injection Botulinum Toxin Type B


Read all of this leaflet carefully before you start using this medicine because it contains important information for you.


  1. Contents of the pack and other information What NeuroBloc contains

The active substance is Botulinum Toxin Type B. One millilitre (ml) contains 5000 U.


One vial of 0.5 ml contains 2500 U of Botulinum Toxin Type B. One vial of 1 ml contains 5000 U of Botulinum Toxin Type B. One vial of 2 ml contains 10,000 U of Botulinum Toxin Type B.


The other ingredients are disodium succinate, sodium chloride, human serum albumin solution, hydrochloric acid (for pH adjustment) and water for injections.


What NeuroBloc looks like and contents of the pack

NeuroBloc is presented as a solution for injection in a vial that contains 0.5 ml (2500 Units), 1.0 ml (5000 Units) or 2.0 ml (10,000 Units). The solution is clear and colourless to pale yellow.


Pack size of 1.


Marketing Authorisation holder

Sloan Pharma S.à.r.l.

33, Rue du Puits Romain 8070 Bertrange Luxembourg

Manufacturer

Almac Pharma Services Limited Seagoe Industrial Estate Portadown

Craigavon BT63 5UA

United Kingdom And

Almac Pharma Services (Ireland) Limited Finnabair Industrial Estate

Dundalk Co. Louth A91 P9KD

Ireland


For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:


ae@sloanpharma.com


This leaflet was last revised in <{MM/YYYY}> <{month YYYY}>



-------------------------------------------------------------------------------------------------------------------------

The following information is intended for healthcare professionals only: INSTRUCTIONS FOR USE, HANDLING AND DISPOSAL

NeuroBloc is provided in vials for single use only.


The medicinal product is ready to use and no reconstitution is required. Do not shake.


To allow division of the total dose between several injections, NeuroBloc may be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection (see section 4.2 of Summary of Product Characteristics). Such dilutions with sodium chloride should be done in a syringe, pulling out the desired amount of NeuroBloc into the syringe first, and then adding sodium chloride to the syringe. In non clinical experiments, NeuroBloc solution has been diluted up to 6-fold without any resulting change in potency. Once diluted, the medicinal product must be used immediately as the formulation does not contain a preservative.


Any unused solution, all vials of expired NeuroBloc and equipment used in the administration of the medicinal product should be carefully discarded as Medical Biohazardous Waste in accordance with local requirements. Vials should be visually inspected prior to use. If the NeuroBloc solution is not clear and colourless/light yellow or if the vial appears damaged, the product should not be used, but discarded as Medical Biohazardous Waste in accordance with local requirements.


Decontaminate any spill with 10% caustic solution, or sodium hypochlorite (household chlorine bleach –2 ml (0.5%): 1 litre water) solution. Wear waterproof gloves and soak up the liquid with an appropriate absorbent. Place the absorbed toxin in an autoclave bag, seal it and process as Medical Biohazardous Waste in accordance with local requirements.


Do not use after the expiration date stamped on the vial.